<img src="https://imageproxy.pbkrs.com/https://inews.gtimg.com/om_bt/OGCKhlz5_I5VGd0uSzkL1qiW7W9ab1eWPAaWOQFvXOfdkAA/641?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://inews.gtimg.com/om_bt/OGCKhlz5_I5VGd0uSzkL1qiW7W9ab1eWPAaWOQFvXOfdkAA/641"/>
The situation between the U.S. and Iran has entered a phase of easing. According to Xinhua News Agency, U.S. President Trump stated on social media on the 7th that he agreed to suspend bombing and attack actions against Iran for two weeks. Iran has also released signals of easing, significantly reducing the probability of short-term conflict escalation. Global risk assets are entering a rebound window, with the risk appetite for A-shares quickly recovering. As of the market opening on April 8, the three major indices opened higher collectively, with the Shanghai Composite Index returning to 3,900 points and the Hang Seng Technology Index opening nearly 3% higher, as the market pricing focus returns to fundamentals and performance.
From the perspective of trading and allocation, during the window period of easing geopolitical risks, the main lines of the market rebound clearly focus on three directions.
First, assets with relatively low mid-term valuation positions, large rebound space, and direct benefits from improved liquidity expectations. This direction can focus on Hang Seng Technology ETF E Fund (513010) and Innovative Drugs ETF E Fund (516080), with related stocks: Alibaba-W (09988.HK), Tencent Holdings (00700.HK), WuXi AppTec (02359.HK);
Second, the small-cap growth direction that was previously suppressed by sentiment and has sufficient rebound elasticity, with STAR 200 ETF E Fund (588270) and CSI 1000 ETF E Fund (159633) having experienced significant declines, showing strong rebound potential, related stocks include Zhongwei Semiconductor (688380.SH), Hunan Silver (002716.SZ), Shannon Microelectronics (300475.SZ);
Third, the growth track with performance upgrades during the April earnings season. If a new round of rebound begins, institutional investors are expected to regroup around the growth direction with continuously upgraded performance. STAR 50 ETF E Fund (588080) and Semiconductor Equipment ETF E Fund (159558) are likely to become the core direction for institutional clustering, with representative stocks: Cambricon (688256.SH), Baiwei Storage (688525.SH), Zhaoyi Innovation (603986.SH).
For medium to long-term allocation investors, the current Shanghai Composite Index is still below 3,900 points, and the consensus expectation for A-share profit growth in 2026 remains at double-digit high growth. Increasing equity positions through Shanghai Composite Index ETF E Fund (530060) is an efficient choice to seize market upward opportunities and respond to style rotations

513130

516930

589850

The situation between the U.S. and Iran has eased, and Trump has agreed to suspend attacks on Iran, leading to a rebound in global risk assets. The market is focusing on three major investment directions: 1) undervalued assets, such as Hang Seng Technology ETF and innovative drugs ETF; 2) oversold small-cap growth stocks, such as Science and Technology Innovation Board 200 ETF; 3) growth sectors with upward revisions in performance, paying attention to STAR 50 ETF and semiconductor equipment ETF. Medium to long-term investors can increase equity positions through SSE Index ETF to seize market opportunities

腾讯新闻 - 财经

Huatai-PB CSOP Hang Seng Technology ETF(QDII)

Minsheng Royal CSI Biotechnology Theme ETF

Eastmoney Fund SSE Science and Technology Innovation Board 50 ETF

CSOP STAR 50

GF CSI HK Innovative Drugs Industry ETF(QDII)

GTJA Allianz CSI All Share Semiconductors & Semiconductor Equipment ETF

Yinhua CNI HK Connect Innovative Drugs ETF

ICBCCS SZSE ChiNext 50 ETF

Yinhua CSI Innovative Drugs Industry ETF

China Merchants CSI Biotechnology Theme ETF

Penghua SSE Science and Technology Innovation Board 50 ETF

Guotai CES Semiconductor Chip Industry ETF

Hang Seng TECH Index

E Fund CSI Biotechnology Theme ETF

Fullgoal SSE Composite ETF

Hang Seng TECH ETF I

Guotai SSE Composite ETF

Huatai-PB SSE Science and Technology Innovation Board 200 ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

First Trust NYSE Arca Biotech Index Fd

Guotai SSE Science and Technology Innovation Board 200 ETF

Tianhong Hang Seng TECH ETF(QDII)

GF Fund SSE Science and Technology Innovation Board 200 ETF

GTJA Allianz SSE STAR Chip Design Thematic ETF

Dacheng Hang Seng Technology ETF(QDII)

SSE Index

Fullgoal SSE Science and Technology Innovation Board 200 ETF

ChinaAMC CSI Biotechnology Theme ETF

The situation between the US and Iran has eased, risk appetite has warmed, and three main lines are grasping the rebound opportunities